OtherArticle
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation Through A Lipid Rafts Mediated Mechanism
Daniela Sarnataro, Simona Pisanti, Antonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, Chiara Laezza and Maurizio Bifulco
Molecular Pharmacology July 5, 2006, DOI: https://doi.org/10.1124/mol.106.025601
Daniela Sarnataro
Simona Pisanti
Antonietta Santoro
Patrizia Gazzerro
Anna Maria Malfitano
Chiara Laezza
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation Through A Lipid Rafts Mediated Mechanism
Daniela Sarnataro, Simona Pisanti, Antonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, Chiara Laezza and Maurizio Bifulco
Molecular Pharmacology July 5, 2006, DOI: https://doi.org/10.1124/mol.106.025601
OtherArticle
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation Through A Lipid Rafts Mediated Mechanism
Daniela Sarnataro, Simona Pisanti, Antonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, Chiara Laezza and Maurizio Bifulco
Molecular Pharmacology July 5, 2006, DOI: https://doi.org/10.1124/mol.106.025601
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement